Oneliner_1007

OneLiner

First-line therapy for patients with active TB includes isoniazid, rifampin, pyrazinamide, and ethambutol. Rifampin inhibits bacterial RNA synthesis by binding to the ß subunit of DNA-dependent RNA polymerase and blocking transcription. Rifampin has the classic benign side effect of turning bodily fluids orange or red.